跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JORVEZA budesonide 1 mg orally disintegrating tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
JORVEZA budesonide 1 mg orally disintegrating tablet blister pack
Approved
STANDARD
JORVEZA budesonide 1 mg orally disintegrating tablet blister pack
Dr Falk Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
072cd8a24b1c7313
Company
Dr Falk Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
072cd8a24b1c7313
Product Name
JORVEZA budesonide 1 mg orally disintegrating tablet blister pack
Artg Id
322645
Artg Name
JORVEZA budesonide 1 mg orally disintegrating tablet blister pack
Sponsor
Dr Falk Pharma Australia Pty Ltd
Company Detail Path
/organization/dr-falk-pharma-australia-pty-ltd
Artg Date
2020-09-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/304d968affb66374910e65f4f0fb3b69.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/122e8a02bec32c25085432b903d0a957.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
072cd8a24b1c7313
Type
Standard
Back to TGA Approvals